BIOMERICA INC (BMRA) Form 10-Q Quarterly Reports
BIOMERICA INC (BMRA) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BMRA
CIK: 73290
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 05/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haskell & White LLP
Auditor SinceSince 5/31/2022 12:00:00 AM
Lead Engagement PartnerRichard Smetanka
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| DEF 14A | 2026-10-16 | 2026-10-16 | DEF 14A | 0001493152-26-047438 | View SEC Doc Filr Page |
| 10-Q | 2026-10-15 | 2026-08-31 | 10-Q | 0001493152-26-047271 | View SEC Doc Filr Page |
| 8-K | 2026-10-15 | 2026-10-09 | 8-K | 0001493152-26-047270 | View SEC Doc Filr Page |
| EFFECT | 2026-10-07 | — | EFFECT Filing | 9999999995-26-003175 | View SEC Doc Filr Page |
| EFFECT | 2026-10-07 | — | EFFECT Filing | 9999999995-26-003174 | View SEC Doc Filr Page |
| 10-K/A | 2026-09-28 | 2026-05-31 | 10-K/A | 0001493152-26-044621 | View SEC Doc Filr Page |
| S-3 | 2026-09-24 | — | S-3 | 0001493152-26-044169 | View SEC Doc Filr Page |
| S-3 | 2026-09-24 | — | S-3 | 0001493152-26-044165 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-08-25 | 3 Filing | 0001213900-26-098843 | View SEC Doc Filr Page |
| 3 | 2026-09-08 | 2026-08-27 | 3 | 0001493152-26-041784 | View SEC Doc Filr Page |
| 10-K | 2026-08-31 | 2026-05-31 | 10-K | 0001493152-26-040851 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-28 | — | SCHEDULE 13D Filing | 0001213900-26-095193 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-26 | 4 | 0001493152-26-040454 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-26 | 4 | 0001493152-26-040450 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-26 | 4 | 0001493152-26-040448 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-26 | 4 | 0001493152-26-040444 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-26 | 4 | 0001493152-26-040443 | View SEC Doc Filr Page |
| 8-K | 2026-08-26 | 2026-08-20 | 8-K | 0001493152-26-040251 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-05-29 | 8-K | 0001493152-26-027290 | View SEC Doc Filr Page |
| 10-Q | 2026-04-13 | 2026-02-28 | 10-Q | 0001493152-26-016388 | View SEC Doc Filr Page |
| S-8 | 2026-02-27 | — | S-8 | 0001493152-26-008372 | View SEC Doc Filr Page |
| 4 | 2026-01-28 | 2025-12-12 | 4 | 0001493152-26-004083 | View SEC Doc Filr Page |
| 10-Q | 2026-01-14 | 2025-11-30 | 10-Q | 0001493152-26-002286 | View SEC Doc Filr Page |
| 4 | 2025-12-31 | 2025-12-12 | 4 | 0001493152-25-029843 | View SEC Doc Filr Page |
| 4 | 2025-12-31 | 2025-12-12 | 4 | 0001493152-25-029842 | View SEC Doc Filr Page |